Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD19 Positive Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05336409
What this trial is testing

CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

Who this might be right for
R/R CD19-Positive B-Cell MalignanciesIndolent Non-Hodgkin LymphomaAggressive Non-Hodgkin Lymphoma
Century Therapeutics, Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT04440436
What this trial is testing

Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients

Who this might be right for
NHL
Beijing Immunochina Medical Science & Technology Co., Ltd. 52
Early research (Phase 1)UnknownNCT03599375
What this trial is testing

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, B-Cell
jiuwei cui 20
Testing effectiveness (Phase 2)WithdrawnNCT03579927
What this trial is testing

CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma

Who this might be right for
CD19 PositiveMantle Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma+4 more
M.D. Anderson Cancer Center
Early research (Phase 1)UnknownNCT03720457
What this trial is testing

Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory CD19-positive Lymphoma.

Who this might be right for
CD19-positiveDiffuse Large B-cell LymphomaFollicular Lymphoma
Hrain Biotechnology Co., Ltd. 18
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Early research (Phase 1)Active Not RecruitingNCT04007029
What this trial is testing

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
CD19 PositiveCD20 PositiveRecurrent Chronic Lymphocytic Leukemia+11 more
Jonsson Comprehensive Cancer Center 24
Early research (Phase 1)Ended earlyNCT05987605
What this trial is testing

Phase I/II Clinical Study of 1A46 Drug Substance

Who this might be right for
Advanced Malignancies
BioRay Pharmaceutical Co., Ltd. 4
Early research (Phase 1)Study completedNCT00796731
What this trial is testing

SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaNon-Hodgkin
Sanofi 77
Early research (Phase 1)UnknownNCT06478381
What this trial is testing

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphomas
Henan Cancer Hospital 22
Early research (Phase 1)Study completedNCT02746952
What this trial is testing

Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Institut de Recherches Internationales Servier 25
Testing effectiveness (Phase 2)Study completedNCT03480438
What this trial is testing

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

Who this might be right for
B-Precursor ALL
Goethe University 52
Testing effectiveness (Phase 2)Looking for participantsNCT06533579
What this trial is testing

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaLarge B-cell LymphomaChronic Lymphocytic Leukemia+10 more
Vironexis Biotherapeutics Inc. 32
Testing effectiveness (Phase 2)UnknownNCT02819583
What this trial is testing

CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Study completedNCT04067414
What this trial is testing

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma+1 more
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05460533
What this trial is testing

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 30
Early research (Phase 1)Looking for participantsNCT07133997
What this trial is testing

Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT07584889
What this trial is testing

Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies

Who this might be right for
B Cell LymphomaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Shenzhen University General Hospital 10
Early research (Phase 1)Ended earlyNCT02106091
What this trial is testing

Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL

Who this might be right for
Relapsed B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma
Affimed GmbH 16
Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Next Page